TREATMENT OF PARKINSONISM BY L-DOPA AND DOPA-DECARBOXYLASE INHIBITOR IN A SINGLE TABLET

被引：0
|
作者：
SAROVAPI.I
BRAHAM, J
机构：
[1] HAIM SHEBA MED CTR,DEPT NEUROL,TEL HASHOMER,ISRAEL
[2] TEL AVIV UNIV,MED SCH,TEL AVIV,ISRAEL
来源：
HAREFUAH | 1974年 / 87卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：208 / 210
页数：3
相关论文
共 50 条
  • [21] TREATMENT OF PARKINSONS DISEASE WITH L-DOPA AND DECARBOXYLASE INHIBITOR
    RINNE, UK
    SONNINEN, V
    SIIRTOLA, T
    ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (01): : 1 - &
  • [22] SUPPRESSION OF L-DOPA-INDUCED CIRCLING IN RATS WITH NIGRAL LESIONS BY BLOCKADE OF CENTRAL DOPA-DECARBOXYLASE - IMPLICATIONS FOR MECHANISM OF ACTION OF L-DOPA IN PARKINSONISM
    MELAMED, E
    HEFTI, F
    BITTON, V
    GLOBUS, M
    NEUROLOGY, 1984, 34 (12) : 1566 - 1570
  • [23] TREATMENT OF IDIOPATHIC PARKINSONISM WITH L-DOPA IN THE ABSENCE AND PRESENCE OF DECARBOXYLASE INHIBITORS - EFFECTS ON PLASMA-LEVELS OF L-DOPA, DOPA DECARBOXYLASE, CATECHOLAMINES AND 3-O-METHYL-DOPA
    BOOMSMA, F
    MEERWALDT, JD
    INTVELD, AJM
    HOVESTADT, A
    SCHALEKAMP, MADH
    JOURNAL OF NEUROLOGY, 1989, 236 (04) : 223 - 230
  • [24] L-DOPA FOR PARKINSONISM
    REVENO, WS
    BAUER, RB
    ROSENBAUM, H
    GERIATRICS, 1973, 28 (01) : 86 - 88
  • [25] TREATMENT OF PARKINSONISM WITH L-DOPA ASSOCIATED WITH DECARBOXYLASE INHIBITORS .2.
    GAUTHIER, G
    DEAJURIA.J
    SIMONA, B
    CONSTANTINIDIS, J
    EISENRING, JJ
    KRASSOIEVITCH, M
    YANNIOTIS, G
    TISSOT, R
    REVUE NEUROLOGIQUE, 1970, 123 (05) : 297 - +
  • [26] Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease
    Devos, David
    Lejeune, Stephanie
    Cormier-Dequaire, Florence
    Tahiri, Khadija
    Charbonnier-Beaupel, Fanny
    Rouaix, Nathalie
    Duhamel, Alain
    Sablonniere, Bernard
    Bonnet, Anne-Marie
    Bonnet, Cecilia
    Zahr, Noel
    Costentin, Jean
    Vidailhet, Marie
    Corvol, Jean-Christophe
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (02) : 170 - 175
  • [27] TREATMENT OF PARKINSONISM WITH ORAL L-DOPA COMBINED WITH A DECARBOXYLASE INHIBITOR (RO4 46.02)
    TISSOT, R
    GAILLARD, JM
    GUGGISBERG, M
    GAUTHIER, G
    DEAJURIA.J
    PRESSE MEDICALE, 1969, 77 (17): : 619 - +
  • [28] LONG-TERM TREATMENT OF PARKINSONS-DISEASE WITH L-DOPA AND DOPA-DECARBOXYLASE INHIBITOR - THERAPEUTIC RESULTS AND SIDE-EFFECTS
    BATTISTIN, L
    MENEGHETTI, G
    RIGOTTI, S
    SAIA, A
    ACTA NEUROLOGICA SCANDINAVICA, 1978, 57 (02): : 186 - 192
  • [29] STUDY OF DETERIORATION IN LONG-TERM TREATMENT OF PARKINSONISM WITH L-DOPA PLUS DECARBOXYLASE INHIBITOR
    LUDIN, HP
    BASSVERREY, F
    JOURNAL OF NEURAL TRANSMISSION, 1976, 38 (3-4) : 249 - 258
  • [30] L-DOPA AND PARKINSONISM
    CALNE, DB
    SANDLER, M
    NATURE, 1970, 226 (5240) : 21 - +
12345